Combined malonic and methylmalonic aciduria: exome sequencing reveals mutations in the ACSF3 gene in patients with a non-classic phenotype

BackgroundCombined Malonic and Methylmalonic Aciduria (CMAMMA) is a rare recessive inborn error of metabolism characterised by elevations of urine malonic acid (MA) and methylmalonic acid (MMA). Nearly all reported cases are caused by malonyl-CoA decarboxylase (MCD) deficiency. Most patients have me...

Full description

Saved in:
Bibliographic Details
Published inJournal of medical genetics Vol. 48; no. 9; pp. 602 - 605
Main Authors Alfares, Ahmed, Nunez, Laura Dempsey, Al-Thihli, Khalid, Mitchell, John, Melançon, Serge, Anastasio, Natascia, Ha, Kevin C H, Majewski, Jacek, Rosenblatt, David S, Braverman, Nancy
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group Ltd 01.09.2011
BMJ Publishing Group
BMJ Publishing Group LTD
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:BackgroundCombined Malonic and Methylmalonic Aciduria (CMAMMA) is a rare recessive inborn error of metabolism characterised by elevations of urine malonic acid (MA) and methylmalonic acid (MMA). Nearly all reported cases are caused by malonyl-CoA decarboxylase (MCD) deficiency. Most patients have metabolic acidosis, developmental delay, seizures and cardiomyopathy. CMAMMA was also described in symptomatic patients with normal MCD activity, suggesting heterogeneity in this disorder.Methods and resultsWe identified two probands with a non-classical CMAMMA variant through the Quebec newborn urine screening program. While they share the biochemical phenotype of elevated MA and MMA, the MMA excretion was higher than MA, the clinical courses were benign, MYLCD gene sequencing was normal and MCD activity, measured in one proband, was normal. Using exome sequencing in the single consanguineous proband, we identified a homozygous missense allele in the ACSF3 gene, encoding an Acyl-CoA Synthetase (ACS) with unknown substrate and function. The second proband was homozygous for a different ACSF3 missense allele. Both substitutions were in conserved residues and were identified in less than 0.5% of their respective ethnic control populations.ConclusionThese results suggest that ACSF3 is a candidate gene for non-classical CMAMMA observed in our patients and document the value of exome sequencing of a limited number of patients for the identification of novel disease genes.
Bibliography:href:jmedgenet-48-602.pdf
local:jmedgenet;48/9/602
ArticleID:jmedgenet-2011-100230
PMID:21785126
istex:17958E9FD9F36CDF6CE4774F2DB5ED9DE115EA44
ark:/67375/NVC-QVCTN552-L
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2593
1468-6244
DOI:10.1136/jmedgenet-2011-100230